Projects per year
Organization profile
Organization profile
The Georgia Cancer Center is on a mission for Georgia providing industry-leading cancer research and care that benefits patients locally and globally. Our ultimate goal is to eradicate cancer and we are proudly making progress every day. When we say patient care is a priority, we mean it. We assemble custom teams of field experts to address each individual’s unique needs.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Cancer Center is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Projects
- 8 Finished
-
Cellular Sources Of Neuregulin 1 (NRG1) Regulating Neural Activity And Behavior
Bergson, C. M. (PI) & Mei, L. (CoPI)
NATIONAL INSTITUTE OF MENTAL HEALTH
8/1/16 → 7/31/19
Project: Research project
-
Swedish APP mutation and NMJ decline in Alzheimer's disease
Mei, L. (CoPI), Xiong, W. C. (PI) & Zigmond, R. R. E. (CoPI)
9/30/15 → 8/31/25
Project: Research project
-
Characterization of Agrin/LRP4 Antibody-Positive Myasthenia Gravis
Mei, L. (CoPI) & Mei, L. (PI)
National Institute of Neurological Disorders and Stroke
7/15/15 → 6/30/20
Project: Research project
-
Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia
Miranda-Galvis, M., Tjioe, K. C., Sharara, M., Maloney, M., Keruakous, A. R., Jillella, A., Kota, V., Guha, A. & Cortes, J. E., Sep 11 2025, (E-pub ahead of print) In: Leukemia.Research output: Contribution to journal › Article › peer-review
-
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer
Foote, J. B., Mattox, T. E., Keeton, A. B., Chen, X., Smith, F. T., Berry, K., Holmes, T. W., Wang, J., Huang, C. H., Ward, A., Mitra, A. K., Ramirez-Alcantara, V., Hardy, C., Fleten, K. G., Flatmark, K., Yoon, K. J., Sarvesh, S., Nagaraju, G. P., Bandi, D. S. R. & Maxuitenko, Y. Y. & 15 others, , 2025, In: Cancer Research. 85, 5, p. 956-972 17 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2
Brown, Z., Scott, C., Zhang, L. F., Sadek, R., Clarke, A., Jillella, A., Keruakous, A. R. & Clemmons, A. B., Sep 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 9, p. 642-647 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations